Seattle, WA -- (SBWire) -- 10/02/2019 --Cell Therapy Manufacturing Market, by Therapy Type (Allogeneic Cell Therapy and Autologous Cell Therapy) by Technology (Somatic Cell Technology, Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology, Cell Plasticity Technology, and 3D Technology), by Source (IPSC's, Bone Marrow, Umbilical Cord, Adipose Tissue, and Neural Stem Cells), by Application ( Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, and Other), and by Region - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2019-2027
Cell therapy is a medical procedure which primarily used for the restoration of damaged tissue and has broad application in treating various infectious and chronic disease such as metabolic disorders, immune deficiency, tissue degradation, and cancer. Cell therapy is classified into two types' i.e. autologous (one's own body's cells) and allogeneic (third party donor's cells). Cell therapy technique has gained rapid adoption in recent past years as it is widely used to restore the lost function of tissues and cells rather than to developing a new organ. Recently, few cell therapies have been approved for a clinical trial. For instance, in 2013 a stage 2 clinical trial was completed for transplantation of bone marrow-derived stem cells in affected knee by rheumatoid arthritis. The growth of this technique is also increased due to the involvement of government agencies. For instance, innovate U.K. 2014 report showed that the government agreed to fund US$15.3 million in cell therapy manufacturing market.
Get Demo PDF Brochure of Research @ https://www.coherentmarketinsights.com/insight/request-pdf/1728
Market Dynamics
The rising number of surgical procedure around the globe along with a growing number of trauma and accident cases are predominantly fueling the market growth. For instance, according to a 2015, World Health Organization (WHO) report, more than 50,000 stem cell transplants are carried out annually worldwide for various surgeries. Moreover, stem cell transplantation has emerged as promising medical therapy for patients suffering from highly advanced stages disease like blindness, Alzheimer's, autism, arthritis, cancer, cerebral palsy, diabetes, etc. Key biopharmaceutical companies are majorly investing in research for cell therapy. For instance, Longeveron LL, a biopharmaceutical company received a US$ 750,000 grant from the Maryland Technology Development Corporation (TEDCO) in 2018 for stem cell therapy research. These agreement and government financial support are further augmenting the growth of the cell therapy market. On the other hand, the stringent rules and regulations along with the health safety issues over cell therapy treatment are anticipated to limit the market growth.
Regional Insights
From the geographical point of view, the global cell therapy market is studied across the region of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is dominating the overall market and is likely to maintain its dominance over the forecast period. The growth in the North America market primarily depends on the growing number of surgeries in the region as well as the development of advanced therapy. According to the National Health Statistics Report by the Centers for Disease Control & Prevention (CDC), around 201,748.3 million surgical and non-surgical procedures were performed in the U.S. in 2011.
Moreover, the Asia Pacific market is assumed to gain significant growth in the overall cell therapy manufacturing market in the upcoming years
Marginal market share would be grabbed by the local players entering into market owing to less stringent regulatory requirements and increasing number of customer pool prone to suffering from various chronic disease such as cancer, HIV, hepatitis, etc. hence the advent of cell therapy can offer enhanced solutions to the patient at the marginally lower cost.
Competitive Insights
The key player operating in the global cell therapy manufacturing market include, Pharmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec. Key players are adopting smart strategies such as collaborations, introduction of new technologies and devices to expand their position in the market. For instance, in 2014, ViaCyte, Inc. successfully implanted VC-01 an embryonic stem cell derived islet for the treatment of type 1 diabetes.
For More Details On this Report: https://www.coherentmarketinsights.com/ongoing-insight/cell-therapy-manufacturing-market-1728
Market Segmentation:
By Therapy Type:
- Allogeneic Cell Therapy
- Autologous Cell Therapy
By Technology:
- Somatic Cell Technology
- Cell Immortalization Technology
- Viral Vector Technology
- Genome Editing Technology
- Cell Plasticity Technology
- 3D Technology
By Source:
- IPSC's (Induced pluripotent stem cell)
- Bone marrow
- Umbilical cord
- Adipose tissue
- Neural stem
By Application:
- Musculoskeletal
- Cardiovascular
- Gastrointestinal
- Neurological
- Oncology
- Dermatology
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
To Buy This Exclusive Report @ https://www.coherentmarketinsights.com/insight/buy-now/1728
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Cell Therapy Manufacturing Market Distribution, Reimbursement, Strategies for Pricing, Cost Control